Impact of Genetic Variants in ABCG2, NR1I2 and UGT1A1 on the Pharmacokinetics of Dolutegravir in Children. Spector SA, Brummel SS, Chang A, Wiznia A, et al. J Acquir Immune Defic Syndr 2024 Jan 3. doi: 10.1097/QAI.0000000000003358.

Read + Share

Amedeo Smart

Independent Medical Education

Spector SA, Brummel SS, Chang A, Wiznia A, et al. Impact of Genetic Variants in ABCG2, NR1I2 and UGT1A1 on the Pharmacokinetics of Dolutegravir in Children. J Acquir Immune Defic Syndr 2024 Jan 3. doi: 10.1097/QAI.0000000000003358.
PMID: 38180896